Neumora Therapeutics, Inc. - NMRA
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 25
Latest filed: Aug 21, 2026
| Form | Count |
|---|---|
| 4 | 11 |
| 8-K | 6 |
| 144 | 5 |
| SCHEDULE 13G/A | 2 |
| SCHEDULE 13D/A | 1 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Aug 21, 2026 | 144 | — | 0001964306-26-000408 | View |
| Aug 21, 2026 | 4 | Aug 20, 2026 | 0001610717-26-000385 | View |
| Aug 21, 2026 | 4 | Aug 20, 2026 | 0001610717-26-000384 | View |
| Aug 21, 2026 | 4 | Aug 20, 2026 | 0001610717-26-000383 | View |
| Aug 21, 2026 | 4 | Aug 20, 2026 | 0001610717-26-000382 | View |
| Aug 21, 2026 | 4 | Aug 20, 2026 | 0001610717-26-000381 | View |
| Aug 20, 2026 | 144 | — | 0001964306-26-000403 | View |
| Aug 19, 2026 | 4 | Aug 17, 2026 | 0001610717-26-000362 | View |
| Aug 19, 2026 | 144 | — | 0001964306-26-000401 | View |
| Aug 18, 2026 | 144 | — | 0001964306-26-000400 | View |
| Aug 17, 2026 | 144 | — | 0001964306-26-000398 | View |
| Aug 14, 2026 | 8-K | Aug 14, 2026 | 0001193125-26-350349 | View |
| Jul 27, 2026 | 8-K | Jul 27, 2026 | 0001193125-26-316819 | View |
| Jun 15, 2026 | 8-K | Jun 10, 2026 | 0001193125-26-270328 | View |
| May 29, 2026 | 8-K | May 27, 2026 | 0001193125-26-248244 | View |
| May 29, 2026 | 4 | May 27, 2026 | 0001610717-26-000169 | View |
| May 29, 2026 | 4 | May 27, 2026 | 0001610717-26-000170 | View |
| May 29, 2026 | 4 | May 27, 2026 | 0001610717-26-000171 | View |
| May 29, 2026 | 4 | May 27, 2026 | 0001610717-26-000173 | View |
| May 29, 2026 | 4 | May 27, 2026 | 0001610717-26-000174 | View |
| May 15, 2026 | SCHEDULE 13G/A | — | 0000905148-26-002417 | View |
| May 07, 2026 | 8-K | May 07, 2026 | 0001193125-26-210310 | View |
| May 04, 2026 | SCHEDULE 13G/A | — | 0002005369-26-000023 | View |
| Apr 01, 2026 | SCHEDULE 13D/A | — | 0001012975-26-000294 | View |
| Mar 30, 2026 | 8-K | Mar 30, 2026 | 0001193125-26-130372 | View |